title: Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans.
abstract: Niosomes have potential applications in topical drug delivery system. The objective of the study was to formulate and evaluate the niosome of Itraconazole. Surfactant : cholesterol ratio and quantity of ethanol used were studied by applying factorial design. Formulated niosomes were evaluated for vesicle size, entrapment efficiency, drug release, skin permeation, and antimycotic activity. Vesicle size, entrapment efficiency, and drug release were markedly dependent on surfactant : cholesterol ratio and quantity of ethanol used. Permeation of the drug through the skin was affected by cholesterol content in formulation. Itraconazole niosome were having larger zone of inhibition than marketed formulation when activity was checked against C. albicans. Niosomes may be a promising carrier for topical delivery of Itraconazole especially due to their simple production.
authors: Department of Pharmaceutics, R. C. Patel Institute of Pharmaceutical Education and Research, Maharashtra, Shirpur 425405, India.
authors: Vijay D
authors: VD
authors: Wagh
authors: Onkar J
authors: OJ
authors: Deshmukh
references: Biophys J. 1997 Mar;72(3):1264-77
references: 9138572
references: Biochemistry. 1994 Jul 5;33(26):8082-8
references: 8025114
references: Int J Pharm. 2008 Sep 1;361(1-2):104-11
references: 18577437
references: ISRN Pharm. 2012;2012:738432
references: 22474607
references: Int J Pharm. 2001 Mar 14;215(1-2):91-9
references: 11250095
references: Pak J Pharm Sci. 2009 Apr;22(2):131-8
references: 19339221
references: Int J Pharm. 2008 Aug 6;360(1-2):156-63
references: 18539416
references: AAPS PharmSciTech. 2002;3(4):E35
references: 12916929
references: J Control Release. 1998 Jul 31;54(2):149-65
references: 9724902
references: Eur J Pharm Biopharm. 2007 Sep;67(2):398-405
references: 17452098
references: ISRN Pharm. 2012;2012:636743
references: 22500244
references: Eur J Pharm Biopharm. 2005 Apr;59(3):485-90
references: 15760729
references: J Pharm Pharmacol. 1991 Mar;43(3):154-61
references: 1675270
references: J Pharm Sci. 1994 Sep;83(9):1189-203
references: 7830230
references: Int J Pharm. 2006 Feb 3;308(1-2):140-8
references: 16356669
references: J Pharm Biomed Anal. 2001 Oct;26(3):387-99
references: 11489384